Literature DB >> 34165717

Chromatin Regulation at Parental Gene Promoters by Pseudogene Sense lncRNAs.

Stefan Schoeftner1,2, Michele Scarola3, Roberta Benetti4,5.   

Abstract

There is accumulating evidence that pseudogenes can produce functionally relevant lncRNAs in a tightly controlled manner. This class of transcripts has been demonstrated to play an important role in development and disease, by controlling parental gene expression. Classically, pseudogene derived lncRNAs compete with parental transcripts for miRNAs or factors that control parental mRNA metabolisms. Recently, pseudogene lncRNAs were demonstrated to take over the control of classic chromatin modifying enzymes and alter parental gene promoter activity or genome wide gene expression. Here, we discuss a new mechanism of parental gene expression controlled by the mOct4P4 lncRNA, a sense transcript derived from the murine Oct4 pseudogene 4. mOct4P4 lncRNA specifically interacts with the RNA binding protein FUS and the Histone Methyltransferase SUV39H1 to target heterochromatin formation at the parental Oct4 promoter in trans. In addition, we will address key issues for the functional dissection of epigenetic control of parental gene promoters by pseudogene lncRNAs.

Entities:  

Keywords:  FUS; Oct4; Oct4 pseudogenes; SUV39H1; hOCT4P3; lncRNA; mOct4; mOct4P4

Year:  2021        PMID: 34165717     DOI: 10.1007/978-1-0716-1503-4_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Transient pairing of homologous Oct4 alleles accompanies the onset of embryonic stem cell differentiation.

Authors:  Megan S Hogan; David-Emlyn Parfitt; Cinthya J Zepeda-Mendoza; Michael M Shen; David L Spector
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

  1 in total
  1 in total

Review 1.  Pseudogenes and Liquid Phase Separation in Epigenetic Expression.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Usman Ayub Awan; Dandan Wang; Na Fang; Wenqiang Wei; Weijuan Zhang; Shaoping Ji
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.